Organisations can apply for a share of £6 million, inclusive of VAT, to develop or repurpose platform technologies.
These technologies can be used as clinical tools to enable the bio-marker guided development of transformative dementia therapies.
Eligibility summary
To lead a project, you can:
- be an organisation of any size
- work alone or with other organisations as subcontractors
Contracts will be awarded to a single legal entity only.